Tagged with diabetes

Hungary Calin Galaseanu, recently appointed general manager of Novo Nordisk Hungary, elaborates on the country’s strong treatment paradigm for diabetes. He goes on to highlight Hungary’s key positioning as a strategic affiliate for Novo Nordisk in the areas of market access success and clinical trial capabilities.     Hungary is actually…

Puerto Rico In Puerto Rico, approximately 16 percent of the adult population has diabetes, one the highest prevalence in the world, compared to 10 percent in the general US population. As a result, diabetes represents a significant burden to the local healthcare system and population.   To tackle the rise of diabetes,…

Czech Republic Jan Škrha, president of the Czech Diabetes Society (ČDS), provides insight into the most crucial advances in the quality care of Diabetes, which relies on the indispensable cooperation between specialists and General Practitioners (GPs). Škrha puts a strong emphasis on the importance of early diagnosis and discusses the underestimated role…

China The rate of diabetes in China has exploded: the number of diabetic patients has surpassed 100 million and is expected to increase to 150 million by 2040. Dr Qinghua Wang, founder and CEO of Innogen, returned to China in 2014 with the hope of tackling this disease with Diabegone, an…

UAE The UAE’s rapid economic growth over the last half-century has been accompanied by a surge in lifestyle diseases such as diabetes and obesity. Both public and private organizations are now stepping up to tackle this health and economic burden with expanded access to cutting-edge treatments, a greater focus on education…

Thailand Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of the fastest-growing pharma multinationals in Thailand. Upon this solid foundation, Novo is now looking to bring the company’s latest and most innovative products to Thailand, branch out into obesity treatments, and…

Algeria Yacine Sellam examines how pharmacists in Algeria can follow the lead of their US counterparts and play a greater role in patients’ diabetes management.   Noncommunicable diseases are a growing burden in Algeria. The results of a STEPwise survey revealed that, for adults aged between 18 and 69 years, 23.6…

Korea Industry players – from Big Pharma giants to small local startups – are bringing new, innovative solutions to market in Korea in order to try and solve the country’s diabetes epidemic.   The growing prevalence of Type 2 Diabetes is becoming a global issue. According to Dr Nam Han Cho,…

Taiwan Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to share his mission to fulfil CEO Lars Fruergaard Jørgensen’s strategy of expanding beyond being a leader of diabetes at the…

Puerto Rico After climbing through the ranks from sales representative to leading business units at Eli Lilly Canada, François Gilbert took the reins of Eli Lilly’s Puerto Rican affiliate last year. Among other things, he shares the reasons why Eli Lilly invests in strong commercial capabilities and clinical operations on the island,…

Canada Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to driving change at a much larger level via a ‘collective impact’ approach.   When I encountered the concept of collective impact in the Stanford Social Innovation Review, I realized the possibilities lay…

Thailand Dr Wannee Nitiyanant, president of the Diabetes Association of Thailand and Dr Supawadee Likitmaskul, president of the Siriraj Diabetes Center of Excellence, highlight the crucial importance of educate the public, patient and the healthcare professional in the diabetes field. They feature the priority of having more collaboration between the multi…